Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
03/2004
03/09/2004US6703403 Method for improving pharmacokinetics
03/09/2004US6703402 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
03/09/2004US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors
03/04/2004WO2004018428A1 Antibacterial benzoic acid derivatives
03/04/2004WO2004018414A2 Antibacterial agents
03/04/2004WO2004018410A1 Substituted benzanilide compound and pest control agent
03/04/2004WO2004017966A1 Five-membered heterocyclic compounds in the treatment of chronic and acute pain
03/04/2004WO2004017965A1 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
03/04/2004WO2004001059A3 Heterocyclic inhibitors of kinases
03/04/2004WO2003106456A3 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity
03/04/2004WO2003032916A3 Organosulfur inhibitors of tyrosine phosphatases
03/04/2004WO2002096867A3 Inhibitors of protein kinase for the treatment of disease
03/04/2004WO2002070469A3 Selective pde3b inhibitors and use of the same in therapy
03/04/2004US20040044221 Anticancer ganets; drug resistance
03/04/2004US20040044049 Compounds for inhibiting insulin secretion and methods related thereto
03/04/2004US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/04/2004US20040044044 Thiazolyl urea compounds and methods of uses
03/04/2004US20040044008 Dietetics; antilipemic agents; non-insulin dependent diabetes; cardiovascular disorders
03/04/2004US20040044004 Calcium channel inhibitors comprising benzhydril spaced from piperazine
03/04/2004US20040043919 Method for the treatment of neurological and neuropsychological disorders
03/04/2004DE10239481A1 New 1-(heterocyclyl-carbonylamino)-cyclopropane-carboxylic acid derivatives, useful as microbicides, especially fungicides or bactericides for protection of plants or materials such as wood
03/03/2004EP1394147A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
03/03/2004EP1392718A2 Improved native chemical ligation with three or more components
03/03/2004EP1392673A2 1,3-dihydroxybenzene derivatives and colorants containing said compounds
03/03/2004EP1392665A1 Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases
03/03/2004EP1392664A1 Epothilone derivatives
03/03/2004EP1392660A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
03/03/2004EP1392652A1 Method for producing 1,3-disubstituted 2-nitroguanidines
03/03/2004EP1392645A2 Aza hydroxylated ethyl amine compounds
03/03/2004EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives
03/03/2004EP1392639A1 Pyruvate derivatives
03/03/2004EP1392637A2 Modulators of peroxisome proliferator activated receptors
03/03/2004EP1392315A1 Methods of treating alzheimer's disease
03/03/2004EP1392280A2 Arylsulfonamide ethers, and methods of use thereof
03/03/2004EP1007039B1 Novel heterocyclic analogs of diphenylethylene compounds
03/03/2004CN1479730A Process for preparing anhydride of aminothiazole derivative
03/03/2004CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor
03/03/2004CN1140519C Trifluoromethylbiphenglyl-dihalophenylazolines as pesticides
03/03/2004CN1140175C Herbicidal agents based on heteroaryloxyacetamides
03/02/2004US6699994 Biaryl compounds as serine protease inhibitors
03/02/2004US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims
03/02/2004US6699895 2-aminothiazoline derivatives and process for preparing the same
03/02/2004US6699893 Glucocorticoid receptor modulators
03/02/2004US6699891 Npyy5 antagonists
03/02/2004US6699890 Phosphodiesterase 4 inhibitors
03/02/2004US6699867 4-(4-Methyl-piperazin-1-ylmethyl)-4,5-dihydrothiazol-2-ylamine
03/02/2004US6699866 For therapy of addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, parkinson's disease, restless leg syndrome, sleeping disorders
03/02/2004US6699854 2-substituted 4-heteroaryl- pyrimidines, inhibitors of cyclin-dependent kinases (cdks)
02/2004
02/26/2004WO2004016601A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
02/26/2004WO2004016600A1 Novel use of benzothiazole derivatives
02/26/2004WO2004016587A1 Nitrogen-containing compounds
02/26/2004WO2004016578A2 Arylethanolamine beta2-adrenoreceptor agonist compounds
02/26/2004WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv
02/26/2004WO2003045334A3 Methods and compositions for ameliorating the undesirable effects of chemotherapy
02/26/2004US20040039180 Diazonium salt, its synthesizing method and recording material
02/26/2004US20040039043 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
02/26/2004US20040039038 Biaromatic compound activators of PPARy-type receptors
02/26/2004US20040039036 Oral solution containing famotidine and edetic acid or a salt
02/26/2004US20040039035 A (Ar1-X-Ar2) compound, where Ar1 and Ar2= aryl, heteroaryl or fused arylheteroaryl, X= secondary or tertiary amine, -C(=O)S, -CH=CHSO2 and -SO2N(R)2, and R=H or alkyl, useful for treating contact hypersensitivity
02/26/2004US20040039029 Thiazolyl urea compounds and methods of uses
02/26/2004US20040038990 Aminothiazole derivatives
02/26/2004US20040038987 Novel cyclic diamine compounds and medicine containing the same
02/26/2004US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc.
02/26/2004US20040038941 Compounds for the treatment of inflammatory disorders
02/26/2004US20040037802 Activated polymeric bicine derivatives such as polypeptides modified with these polymers exhibit reduced immunogenicity/antigenicity and circulate in the blood
02/26/2004US20040037022 Aminoalcohol derivatives
02/26/2004CA2495492A1 Novel use of benzothiazole derivatives
02/25/2004EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials
02/25/2004EP1391450A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide
02/25/2004EP1206447B1 Selective inhibitors of the urokinase plasminogene activators
02/25/2004EP1091648B1 Biocidal composition and its use
02/25/2004EP1087934B1 Aminocyclohexyl ether compounds and uses thereof
02/25/2004EP1005446B1 N-aroylphenylalanine derivatives
02/25/2004CN1478078A Nitrogenous aromatic ring compounds
02/25/2004CN1478077A Benzamide compounds as APOB secretion inhibitors
02/24/2004US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives
02/24/2004US6696477 Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
02/24/2004US6696473 Heterocyclic modulators of nuclear receptors
02/24/2004US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
02/24/2004US6696456 Carbocyclic acids and salts such as (2s,3r)-3-ethylsulfanyl-2-(4'-fluoro-biphenyl-4-sulfonylamino)-3- phenylpropionic acid, used as metalloenzyme antagonists for the prophylaxis of degenerative joint disease and as wound healing agents
02/24/2004US6696451 Dihydropyrimidines
02/24/2004US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example
02/24/2004US6696110 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring
02/19/2004WO2004015131A2 Hepatitis c virus assays
02/19/2004WO2004014915A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
02/19/2004WO2004014903A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
02/19/2004WO2004014885A1 Amino benzothiazole compounds with nos inhibitory activity
02/19/2004WO2004014884A1 Thiazole derivatives
02/19/2004WO2004014883A1 Process for producing acrylonitrile compound
02/19/2004WO2004014871A1 Vanilloid receptor ligands and their use in treatments
02/19/2004WO2004014852A2 Iminothiazolidinones as inhibitors of hcv replication
02/19/2004WO2004014847A1 Mcp-1 receptor antagonists and method of use thereof
02/19/2004WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation
02/19/2004WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
02/19/2004WO2004014424A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers
02/19/2004WO2004014371A1 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
02/19/2004WO2004014369A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
02/19/2004WO2004014313A2 Combination pharmaceutical agents as inhibitors of hcv replication
02/19/2004WO2003060078A9 Heterocyclic modulators of nuclear receptors
02/19/2004WO2002030356A3 Synthesis of epothilones and relates analogs